Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Cardiol Therapeutics's enterprise value was $72.68M on Nov 11, 2026, against $53.26M a year earlier. Over the last 5 years it ranged from -$39.96M to $156.35M, with a median of $53.26M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $72.68M | +58.1% |
| 2025 | Dec 31, 2025 | $45.96M | -21.1% |
| 2024 | Dec 31, 2024 | $58.25M | +660.6% |
| 2023 | Dec 29, 2023 | $7.66M | – |
| 2022 | Dec 30, 2022 | -$39.96M | -190.3% |
| 2021 | Dec 31, 2021 | $44.26M | – |
See a number that looks wrong?